HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intrapleural injection of OK-432 as the primary in-utero treatment for fetal chylothorax.

Abstract
Chylothorax is a rare congenital condition associated with significant perinatal mortality and morbidity. Previous treatments with repeated thoracocentesis or thoracoamniotic shunting were technically demanding, and associated with significant procedure-related complications and neonatal complications. Here we report the first successful case in Hong Kong treated by a simple and effective intervention, namely pleurodesis with OK-432, in a fetus presenting at 20 weeks of gestation with bilateral pleural effusion.
AuthorsViola K T Leung, Stephen S H Suen, Y H Ting, L W Law, T K Lau, T Y Leung
JournalHong Kong medical journal = Xianggang yi xue za zhi (Hong Kong Med J) Vol. 18 Issue 2 Pg. 156-9 (Apr 2012) ISSN: 1024-2708 [Print] China
PMID22477741 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Picibanil
Topics
  • Chylothorax (drug therapy)
  • Female
  • Fetal Diseases (drug therapy)
  • Humans
  • Picibanil (administration & dosage)
  • Pleurodesis
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: